Home » Authors » James Etheridge

Articles by James Etheridge

Cerep Broadening Services Via $12.9M Acquisition of Hesperion

Jan. 21, 2004

By James Etheridge

Cellectis Licenses Technology To Diversa For Use In Research

Jan. 14, 2004

By James Etheridge

UroGene Licenses Aventis Drug, Engages Third Funding Round

Jan. 14, 2004

By James Etheridge

UroGene Licenses Aventis Drug, Engages Third Funding Round

Jan. 14, 2004

By James Etheridge

Cellectis Licenses Technology To Diversa For Use In Research

Jan. 14, 2004

By James Etheridge

Innogenetics Forms Hepatitis C Union With Roche Diagnostics

Jan. 7, 2004

By James Etheridge

Innogenetics Forms Hepatitis C Union With Roche Diagnostics

Jan. 7, 2004

By James Etheridge

Ariana Seeking EUR5M To Push 'Intelligent' Drug Discovery

Dec. 31, 2003

By James Etheridge

Ariana Seeking EUR5M To Push 'Intelligent' Drug Discovery

Dec. 31, 2003

By James Etheridge

UroGene, SGX To Develop Kinase Inhibitors For Urological Cancers

Dec. 24, 2003

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...